BACKGROUND: To explore the relationship between binge eating disorder (BED) and obesity in patients with bipolar disorder (BP). METHODS: 717 patients participating in the Mayo Clinic Bipolar Biobank completed structured diagnostic interviews and questionnaires for demographic and illness-related variables. They also had weight and height measured to determine body mass index (BMI). The effects of BED and obesity (BMI≥30 kg/m(2)), as well as their interaction, were assessed on one measure of general medical burden and six proxies of psychiatric illness burden. RESULTS: 9.5% of patients received a clinical diagnosis of BED and 42.8% were obese. BED was associated with a significantly elevated BMI. Both BED and obesity were associated with greater psychiatric and general illness burden, but illness burden profiles differed. After controlling for obesity, BED was associated with suicidality, psychosis, mood instability, anxiety disorder comorbidity, and substance abuse comorbidity. After controlling for BED status, obesity was associated with greater general medical comorbidity, but lower substance abuse comorbidity. There were no significant interaction effects between obesity and BED, or BMI and BED, on any illness burden outcome. LIMITATIONS: There may have been insufficient power to detect interactions between BED and obesity. CONCLUSIONS: Among patients with BP, BED and obesity are highly prevalent and correlated, but associated with different profiles of enhanced illness burden. As the association of BED with greater psychiatric illness burden remained significant even after accounting for the effect of obesity, BP with BED may represent a clinically important sub-phenotype.
BACKGROUND: To explore the relationship between binge eating disorder (BED) and obesity in patients with bipolar disorder (BP). METHODS: 717 patients participating in the Mayo Clinic Bipolar Biobank completed structured diagnostic interviews and questionnaires for demographic and illness-related variables. They also had weight and height measured to determine body mass index (BMI). The effects of BED and obesity (BMI≥30 kg/m(2)), as well as their interaction, were assessed on one measure of general medical burden and six proxies of psychiatric illness burden. RESULTS: 9.5% of patients received a clinical diagnosis of BED and 42.8% were obese. BED was associated with a significantly elevated BMI. Both BED and obesity were associated with greater psychiatric and general illness burden, but illness burden profiles differed. After controlling for obesity, BED was associated with suicidality, psychosis, mood instability, anxiety disorder comorbidity, and substance abuse comorbidity. After controlling for BED status, obesity was associated with greater general medical comorbidity, but lower substance abuse comorbidity. There were no significant interaction effects between obesity and BED, or BMI and BED, on any illness burden outcome. LIMITATIONS: There may have been insufficient power to detect interactions between BED and obesity. CONCLUSIONS: Among patients with BP, BED and obesity are highly prevalent and correlated, but associated with different profiles of enhanced illness burden. As the association of BED with greater psychiatric illness burden remained significant even after accounting for the effect of obesity, BP with BED may represent a clinically important sub-phenotype.
Authors: Valerie H Taylor; Roger S McIntyre; Gary Remington; Robert D Levitan; Brian Stonehocker; Arya M Sharma Journal: Can J Psychiatry Date: 2012-01 Impact factor: 4.356
Authors: Stephen A Wonderlich; Kathryn H Gordon; James E Mitchell; Ross D Crosby; Scott G Engel Journal: Int J Eat Disord Date: 2009-12 Impact factor: 4.861
Authors: Roger S McIntyre; Susan L McElroy; Jakub Z Konarski; Joanna K Soczynska; Alexandra Bottas; Saulo Castel; Kathryn Wilkins; Sidney H Kennedy Journal: J Clin Psychiatry Date: 2007-09 Impact factor: 4.384
Authors: Erika H Saunders; Laura J Scott; Melvin G McInnis; Margit Burmeister Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-01-05 Impact factor: 3.568
Authors: Ayal Schaffer; Erkki T Isometsä; Jean-Michel Azorin; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Mark Sinyor; Leonardo Tondo; Doris H Moreno; Gustavo Turecki; Catherine Reis; Lars Vedel Kessing; Kyooseob Ha; Abraham Weizman; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham Journal: Aust N Z J Psychiatry Date: 2015-07-14 Impact factor: 5.744
Authors: Mark A Frye; Allen Doederlein; Barbara Koenig; Susan L McElroy; Malik Nassan; Lisa R Seymour; Joanna M Biernacka; Allen S Daniels Journal: Bipolar Disord Date: 2015-08-20 Impact factor: 6.744
Authors: S L McElroy; D E Kemp; E S Friedman; N A Reilly-Harrington; L G Sylvia; J R Calabrese; D J Rabideau; T A Ketter; M E Thase; V Singh; M Tohen; C L Bowden; E E Bernstein; B D Brody; T Deckersbach; J H Kocsis; G Kinrys; W V Bobo; M Kamali; M G McInnis; A C Leon; S Faraone; A A Nierenberg; R C Shelton Journal: Acta Psychiatr Scand Date: 2015-06-26 Impact factor: 6.392
Authors: S J Winham; A B Cuellar-Barboza; A Oliveros; S L McElroy; S Crow; C Colby; D-S Choi; M Chauhan; M Frye; J M Biernacka Journal: Mol Psychiatry Date: 2013-12-10 Impact factor: 15.992
Authors: Stacey J Winham; Alfredo B Cuellar-Barboza; Susan L McElroy; Alfredo Oliveros; Scott Crow; Colin L Colby; Doo-Sup Choi; Mohit Chauhan; Mark A Frye; Joanna M Biernacka Journal: J Affect Disord Date: 2014-04-19 Impact factor: 4.839
Authors: Danielle R Balzafiore; Natalie L Rasgon; Laura D Yuen; Saloni Shah; Hyun Kim; Kathryn C Goffin; Shefali Miller; Po W Wang; Terence A Ketter Journal: Int J Bipolar Disord Date: 2017-08-12
Authors: Yun-Fang Jia; YuBin Choi; Jennifer R Ayers-Ringler; Joanna M Biernacka; Jennifer R Geske; Daniel R Lindberg; Susan L McElroy; Mark A Frye; Doo-Sup Choi; Marin Veldic Journal: Front Cell Neurosci Date: 2017-07-21 Impact factor: 5.505
Authors: Hale Yapici Eser; Anil S Kacar; Can M Kilciksiz; Merve Yalçinay-Inan; Dost Ongur Journal: Front Psychiatry Date: 2018-06-27 Impact factor: 4.157